Treffer 1 - 3 von 3 für Suche 'Kadamyan, V', Suchdauer: 0,32s Treffer weiter einschränken
  1. 1
    Abstract P1-14-06: Everolimus effect on hematologic parameters in a phase II clinical trial for metastatic estrogen receptor (ER) positive breast cancer

    Abstract P1-14-06: Everolimus effect on hematologic parameters in a phase II clinical trial for metastatic estrogen receptor (ER) positive breast cancer von Chen, A, Chen, L, Romond, E, Kadamyan, V, Stevens, M, Chambers, M, Massarweh, S

    Veröffentlicht in Cancer research (Chicago, Ill.)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Abstract P4-02-05: A Phase II Trial of Fulvestrant and RAD001 (Everolimus) in Patients with Metastatic Estrogen Receptor Positive Breast Cancer after Aromatase Inhibitor Failure; a Study in Progress

    Abstract P4-02-05: A Phase II Trial of Fulvestrant and RAD001 (Everolimus) in Patients with Metastatic Estrogen Receptor Positive Breast Cancer after Aromatase Inhibitor Failure; a... von Badin, F, Romond, E, Chambers, M, Shelton, B, Birk, S, Kadamyan, V, Weiss, H, Massarweh, S.

    Veröffentlicht in Cancer research (Chicago, Ill.)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Abstract PD3-8: Whole exome sequencing reveals early mutational change on endocrine and targeted therapy in estrogen receptor (ER)-positive breast cancer

    Abstract PD3-8: Whole exome sequencing reveals early mutational change on endocrine and targeted therapy in estrogen receptor (ER)-positive breast cancer von Massarweh, S, Romond, E, Wang, C, Zeng, Z, Liu, J, Stewart, R, Napier, D, Kadamyan-Melkumyan, V, Farman, M, Black, EP

    Veröffentlicht in Cancer research (Chicago, Ill.)

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: